WVE Wave Life Sciences Ltd. - Ordinary Shares
$5.43
价格 · 八月 19, 2026
截至...的财报数据 七月 30, 2026
关于 Wave Life Sciences Ltd. - Ordinary Shares 公司概况（来自维基百科）
WVE 股票快照 价格、市值、P/E、EPS、ROE、负债/权益、52周范围
价格
$5.43
市值
—
P/E (TTM)
-14.0
每股收益 (TTM)
$-1.21
营收 (TTM)
$43M
股息收益率
—
ROE
—
负债/权益
—
52周区间
$5 – $21
WVE 股价图表 包含技术指标的日 OHLCV — 平移、缩放和自定义您的视图
Configure
10年表现 收入、净利润、利润率和每股收益趋势
营收与净利润
$43M
2016-12-31
→
2025-12-31
EPS
$-1.21
2021-12-31
→
2025-12-31
自由现金流
—
利润率
—
估值 P/E、P/S、P/B、EV/EBITDA 比率 — 该股票是昂贵还是便宜？
指标
5年趋势
WVE
同行中位数
P/E (TTM)
-14.0
19.5
盈利能力 毛利率、营业利润率和净利率；股本回报率 (ROE)、资产回报率 (ROA)、投入资本回报率 (ROIC)
指标
5年趋势
WVE
同行中位数
财务健康 债务、流动性、偿付能力 — 资产负债表强度
指标
5年趋势
WVE
同行中位数
成长 营收、每股收益 (EPS) 和净利润增长：同比、3年复合年增长率 (CAGR)、5年复合年增长率 (CAGR)
指标
5年趋势
WVE
同行中位数
Revenue YoY (营收同比增长)
-60.6%
—
Revenue CAGR 3Y (营收3年复合年增长率)
127.1%
—
Revenue CAGR 5Y (营收5年复合年增长率)
16.3%
—
资本效率 资产周转率、库存周转率、应收账款周转率
指标
5年趋势
WVE
同行中位数
WVE 分析师共识 看涨和看跌分析师观点、12个月价格目标、上涨空间
买入
20 位分析师
- 强烈买入 6 30.0%
- 买入 13 65.0%
- 持有 1 5.0%
- 卖出 0 0.0%
- 强烈卖出 0 0.0%
12个月价格目标
16 位分析师 · 2026-08-17
中位数
$15.00
平均值
$19.06
← 低于所有目标
$5.43
最低
$12.00
最高
$42.00
中位数目标
$15.00
+176.2%
平均目标
$19.06
+251.1%
收益历史 每股收益实际值 vs 预估值，惊喜%，达标率，下次财报日期
平均惊喜
0.01%
| 期间 | EPS Actual | EPS 预期 | 惊喜 |
|---|---|---|---|
| 2026年6月30日 | $-0.34 | $-0.31 | -0.03% |
| 2026年3月31日 | $-0.13 | $-0.33 | 0.20% |
| 2025年12月31日 | $-0.30 | $-0.27 | -0.03% |
| 2025年9月30日 | $-0.32 | $-0.30 | -0.02% |
| 2025年6月30日 | $-0.31 | $-0.29 | -0.02% |
| 2025年3月31日 | $-0.29 | $-0.26 | -0.03% |
完整基本面 所有年度指标 — 损益表、资产负债表、现金流量表
损益表 13
| 指标 | 趋势 | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $43M | $108M | $113M | $4M | $41M | $20M | $16M | $14M | $4M | $1M | $152.0K | |
| R&D Expense | $183M | $160M | $130M | $116M | $122M | $131M | $175M | $134M | $79M | $41M | $9M | |
| SG&A Expense | $75M | $59M | $51M | $51M | $46M | $43M | $49M | $40M | $27M | $16M | $10M | |
| Operating Expenses | $258M | $219M | $181M | $166M | $168M | $173M | $224M | $174M | $106M | $57M | $19M | |
| Operating Income | $-215M | $-110M | $-68M | $-163M | $-127M | $-153M | $-208M | $-160M | $-102M | $-56M | $-19M | |
| Other Non-op | $527.0K | $3M | $2M | $7.0K | $5M | $2M | $10M | $10M | $-331.0K | $-50.0K | $56.0K | |
| Pretax Income | $-204M | $-97M | $-58M | $-161M | $-122M | $-151M | $-194M | $-147M | $-101M | $-55M | $-19M | |
| Income Tax | $0 | $0 | $-677.0K | $681.0K | $-204.0K | $-841.0K | $0 | $69.0K | $842.0K | $482.0K | $44.0K | |
| Net Income | $-204M | $-97M | $-58M | $-162M | $-122M | $-150M | $-194M | $-147M | $-102M | $-56M | $-19M | |
| EPS (Basic) | $-1.21 | $-0.70 | $-0.54 | $-2.05 | $-2.36 | · | · | · | · | · | · | |
| EPS (Diluted) | $-1.21 | $-0.70 | $-0.54 | $-2.05 | $-2.36 | · | · | · | · | · | · | |
| Shares (Basic) | 168,649,795 | 138,277,468 | 106,097,268 | 78,855,810 | 51,825,566 | · | · | · | · | · | · | |
| Shares (Diluted) | 168,649,795 | 138,277,468 | 106,097,268 | 78,855,810 | 51,825,566 | · | · | · | · | · | · |
资产负债表 23
| 指标 | 趋势 | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $602M | $302M | $200M | $88M | $151M | $184M | $147M | $175M | $143M | $150M | $161M | |
| Receivables | $1M | $1M | $21M | · | · | $30M | $20M | $10M | $1M | · | · | |
| Prepaid Expense | $8M | $10M | $10M | $8M | $7M | $10M | $10M | $7M | $7M | $1M | $146.0K | |
| Other Current Assets | $3M | $7M | $4M | $2M | $5M | $5M | $9M | $11M | · | · | · | |
| Current Assets | $615M | $320M | $235M | $99M | $163M | $230M | $185M | $202M | $150M | $152M | $161M | |
| PP&E (Net) | $7M | $10M | $13M | $17M | $22M | $29M | $36M | $40M | $27M | $9M | $3M | |
| PP&E (Gross) | $57M | $56M | $56M | $55M | $54M | $54M | $53M | $49M | $32M | $11M | $4M | |
| Accum. Depreciation | $50M | $46M | $43M | $38M | $32M | $25M | $17M | $10M | $4M | $2M | $2M | |
| Other Non-current Assets | $16.0K | $55.0K | $156.0K | · | · | · | · | · | · | · | · | |
| Total Assets | $638M | $352M | $275M | $146M | $207M | $279M | $284M | $296M | $182M | $165M | $165M | |
| Accounts Payable | $16M | $16M | $13M | $17M | $7M | $14M | $9M | $13M | $8M | $5M | $3M | |
| Accrued Liabilities | $7M | $5M | $2M | $4M | $4M | $2M | $5M | $6M | $3M | · | · | |
| Current Liabilities | $95M | $111M | $186M | $72M | $64M | $121M | $118M | $130M | $18M | $12M | $4M | |
| Capital Leases | $9M | $18M | $25M | $32M | $25M | $26M | $29M | · | · | $16.0K | $78.0K | |
| Other Non-current Liabilities | · | · | · | $190.0K | · | $474.0K | $2M | $2M | $2M | $796.0K | $163.0K | |
| Total Liabilities | $112M | $135M | $227M | $184M | $167M | $189M | $213M | $215M | $34M | $22M | $4M | |
| Common Stock | $1.62B | $1.18B | $935M | $803M | $750M | $694M | $540M | $375M | $310M | $216M | $185M | |
| Paid-in Capital | $228M | $156M | $129M | $119M | $88M | $72M | $57M | $38M | $22M | $10M | $3M | |
| Retained Earnings | $-1.33B | $-1.12B | $-1.02B | $-967M | $-806M | $-683M | $-533M | $-340M | $-193M | $-90M | $-35M | |
| AOCI | $-250.0K | $-262.0K | $-124.0K | $-29.0K | $181.0K | $389.0K | $267.0K | $153.0K | $116.0K | $-291.0K | $41.0K | |
| Stockholders' Equity | $518M | $210M | $40M | $-45M | $32M | $83M | $64M | $73M | $140M | $135M | $153M | |
| Liabilities + Equity | $638M | $352M | $275M | $146M | $207M | $279M | $284M | $296M | $182M | $165M | $165M | |
| Shares Outstanding | 187,660,263 | 153,037,286 | 119,162,234 | 86,924,643 | 59,841,116 | 48,778,678 | 34,340,690 | 29,472,197 | 27,829,079 | 23,502,169 | 21,551,423 |
现金流 10
| 指标 | 趋势 | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| D&A | · | · | · | · | · | · | · | · | $2M | $784.0K | $594.0K | |
| Stock-based Comp | · | · | · | · | · | · | · | · | · | · | $4M | |
| Deferred Tax | $0 | $0 | $0 | · | · | · | · | · | $908.0K | $-698.0K | $36.0K | |
| Operating Cash Flow | $-187M | $-151M | $-19M | $-128M | $-89M | $-116M | $-188M | $-23M | $-84M | $-32M | $-13M | |
| CapEx | $718.0K | $938.0K | $1M | $1M | $560.0K | $1M | $4M | $10M | $19M | $6M | $2M | |
| Investing Cash Flow | $-718.0K | $-938.0K | $-1M | $-1M | $-560.0K | $-1M | $-4M | $-10M | $-19M | $-6M | · | |
| Stock Issued | · | · | $94M | $51M | · | $94M | $162M | $60M | $94M | $30M | $12M | |
| Financing Cash Flow | $488M | $254M | $133M | $67M | $56M | $155M | $164M | $65M | $94M | $29M | · | |
| Net Change in Cash | $300M | $102M | $112M | $-62M | $-34M | $37M | $-28M | $32M | $-8M | $-8M | $160M | |
| Taxes Paid | · | · | · | · | · | · | · | · | $-11.0K | $554.0K | · |
增长率 3
| 指标 | 趋势 | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue YoY | -60.6% | -4.4% | 3005.1% | -91.1% | 104.0% | · | · | · | · | · | · | |
| Revenue CAGR 3Y | 127.1% | 38.3% | 78.0% | · | · | · | · | · | · | · | · | |
| Revenue CAGR 5Y | 16.3% | · | · | · | · | · | · | · | · | · | · |
估值 (TTM) 5
| 指标 | 趋势 | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue TTM | $43M | $108M | $113M | $4M | $41M | $20M | $16M | $14M | $4M | $1M | $152.0K | |
| Net Income TTM | $-204M | $-97M | $-58M | $-162M | $-122M | $-150M | $-194M | $-147M | $-102M | $-56M | $-19M | |
| P/E | -14.0 | -17.7 | -9.4 | -3.4 | -1.3 | · | · | · | · | · | · | |
| P / Tangible Book | 6.2 | 9.0 | 15.2 | · | 5.8 | 4.6 | · | · | · | · | · | |
| Earnings Yield | -7.1% | -5.7% | -10.7% | -29.3% | -75.2% | · | · | · | · | · | · |
损益表 15
| 指标 | 趋势 | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q3 2023 | Q2 2023 | Q1 2023 | Q3 2022 | Q2 2022 | Q1 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $2M | $38M | · | · | $9M | $9M | · | · | $20M | $13M | $49M | $22M | $13M | $285.0K | $375.0K | $2M | |
| R&D Expense | $51M | $47M | $53M | $46M | $43M | $41M | $45M | $41M | $40M | $33M | $32M | $33M | $31M | $28M | $30M | $27M | |
| SG&A Expense | $25M | $22M | $21M | $18M | $18M | $18M | $16M | $15M | $14M | $14M | $13M | $12M | $12M | $12M | $13M | $12M | |
| Operating Expenses | $76M | $70M | $74M | $64M | $61M | $59M | $61M | $56M | $55M | $47M | $45M | $46M | $43M | $39M | $43M | $40M | |
| Operating Income | $-74M | $-31M | $-56M | $-56M | $-53M | $-50M | $23M | $-64M | $-35M | $-34M | $4M | $-23M | $-30M | $-39M | $-42M | $-38M | |
| Interest Income | $5M | $5M | · | $2M | $2M | $3M | · | $2M | $2M | $3M | · | · | · | · | · | · | |
| Other Non-op | $-275.0K | $-80.0K | $234.0K | $324.0K | $-82.0K | $51.0K | $3M | $337.0K | $-18.0K | $365.0K | $171.0K | $118.0K | $1M | $-701.0K | $744.0K | $254.0K | |
| Pretax Income | $-69M | $-26M | $-53M | $-54M | $-50M | $-47M | $29M | $-62M | $-33M | $-32M | $7M | $-21M | $-27M | $-39M | $-41M | $-38M | |
| Income Tax | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $-677.0K | $0 | $0 | $0 | $0 | $0 | |
| Net Income | $-69M | $-26M | $-53M | $-54M | $-50M | $-47M | $29M | $-62M | $-33M | $-32M | $7M | $-21M | $-27M | $-39M | $-41M | $-38M | |
| EPS (Basic) | $-0.34 | $-0.13 | $-0.29 | $-0.32 | $-0.31 | $-0.29 | $0.26 | $-0.47 | $-0.25 | $-0.24 | $0.07 | $-0.20 | $-0.27 | $-0.42 | $-0.62 | $-0.62 | |
| EPS (Diluted) | $-0.34 | $-0.13 | $-0.29 | $-0.32 | $-0.31 | $-0.29 | $0.26 | $-0.47 | $-0.25 | $-0.24 | $0.07 | $-0.20 | $-0.27 | $-0.42 | $-0.62 | $-0.62 | |
| Shares (Basic) | 204,008,712 | 200,167,869 | -325,604,079 | 167,739,208 | 163,987,640 | 162,572,026 | -253,084,680 | 132,563,467 | 129,527,003 | 129,271,678 | 106,025,063 | 105,462,414 | 102,056,712 | 93,900,484 | 66,479,293 | 60,516,616 | |
| Shares (Diluted) | 204,008,712 | 200,167,869 | -325,604,079 | 167,739,208 | 163,987,640 | 162,572,026 | -253,084,680 | 132,563,467 | 129,527,003 | 129,271,678 | 106,975,231 | 105,462,414 | 102,056,712 | 93,900,484 | 66,479,293 | 60,516,616 | |
| EBITDA | $-74M | $-31M | · | $-56M | $-53M | $-50M | · | $-64M | $-35M | $-34M | $4M | $-23M | $-30M | $-39M | $-42M | $-38M |
资产负债表 24
| 指标 | 趋势 | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q3 2023 | Q2 2023 | Q1 2023 | Q3 2022 | Q2 2022 | Q1 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $368M | $545M | $602M | $196M | $208M | $243M | $302M | $311M | $154M | $181M | $140M | $173M | $208M | $97M | $123M | $62M | |
| Short-term Investments | · | · | · | · | · | · | · | · | · | · | · | · | · | $25M | $25M | $50M | |
| Receivables | $888.0K | $0 | $1M | $10M | $2M | · | $1M | $0 | $1M | $0 | $7M | · | · | · | · | · | |
| Prepaid Expense | $12M | $13M | $8M | $7M | $7M | $8M | $10M | $11M | $12M | $11M | $8M | $9M | $9M | $7M | $5M | $7M | |
| Other Current Assets | $4M | $3M | $3M | $3M | $7M | $7M | $7M | $3M | $5M | $5M | $4M | $3M | $3M | $2M | $7M | $6M | |
| Current Assets | $508M | $561M | $615M | $215M | $224M | $258M | $320M | $325M | $172M | $197M | $159M | $185M | $220M | $131M | $160M | $124M | |
| PP&E (Net) | $7M | $7M | $7M | $8M | $9M | $10M | $10M | $11M | $12M | $12M | $14M | $15M | $16M | $19M | $20M | $21M | |
| PP&E (Gross) | · | · | $57M | · | · | · | $56M | · | · | · | · | · | · | · | · | · | |
| Accum. Depreciation | $51M | $50M | $50M | $49M | $48M | $47M | $46M | $45M | $44M | $44M | $42M | $40M | $39M | · | · | · | |
| Other Non-current Assets | $667.0K | $386.0K | $16.0K | $22.0K | $728.0K | $448.0K | $55.0K | · | · | · | · | · | · | · | · | · | |
| Total Assets | $558M | $584M | $638M | $241M | $252M | $288M | $352M | $359M | $209M | $235M | $200M | $230M | $267M | $182M | $213M | $167M | |
| Accounts Payable | $20M | $19M | $16M | $14M | $15M | $14M | $16M | $13M | $18M | $12M | $13M | $12M | $12M | $16M | $11M | $10M | |
| Accrued Liabilities | $5M | $5M | $7M | $5M | $3M | $2M | $5M | $3M | $2M | $2M | $3M | $3M | $2M | $2M | $3M | $3M | |
| Current Liabilities | $51M | $50M | $95M | $86M | $87M | $87M | $111M | $171M | $173M | $166M | $100M | $140M | $133M | $64M | $64M | $58M | |
| Capital Leases | $40M | $7M | $9M | $11M | $14M | $16M | $18M | $20M | $22M | $24M | $27M | $29M | $31M | $34M | $35M | $24M | |
| Other Non-current Liabilities | · | · | · | · | · | · | · | · | · | · | · | $190.0K | $190.0K | · | · | $868.0K | |
| Total Liabilities | $105M | $72M | $112M | $109M | $105M | $109M | $135M | $209M | $204M | $202M | $233M | $274M | $294M | $178M | $174M | $160M | |
| Common Stock | $1.63B | $1.63B | $1.62B | $1.22B | $1.19B | $1.18B | $1.18B | $1.14B | $951M | $950M | $841M | $840M | $838M | $803M | $802M | $751M | |
| Paid-in Capital | $248M | $237M | $228M | $174M | $168M | $161M | $156M | $153M | $136M | $132M | $127M | $125M | $122M | $117M | $113M | $92M | |
| Retained Earnings | $-1.42B | $-1.35B | $-1.33B | $-1.27B | $-1.22B | $-1.17B | $-1.12B | $-1.15B | $-1.09B | $-1.06B | $-1.01B | $-1.02B | $-995M | $-924M | $-885M | $-843M | |
| AOCI | $-172.0K | $-254.0K | $-250.0K | $-190.0K | $-161.0K | $-204.0K | $-262.0K | $-159.0K | $-279.0K | $-198.0K | $-182.0K | $-150.0K | $-50.0K | $-123.0K | $-47.0K | $95.0K | |
| Stockholders' Equity | $454M | $512M | $518M | $125M | $139M | $172M | $210M | $142M | $-3M | $25M | $-40M | $-52M | $-35M | $-5M | $31M | $-53.0K | |
| Liabilities + Equity | $558M | $584M | $638M | $241M | $252M | $288M | $352M | $359M | $209M | $235M | $200M | $230M | $267M | $182M | $213M | $167M | |
| Shares Outstanding | 193,277,622 | 192,337,566 | 187,660,263 | 160,288,481 | 155,673,292 | 154,093,313 | 153,037,286 | 148,392,939 | 122,479,289 | 122,321,384 | 99,011,901 | 98,566,816 | 98,104,844 | 86,841,523 | 86,724,658 | 60,859,968 |
现金流 8
| 指标 | 趋势 | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q3 2023 | Q2 2023 | Q1 2023 | Q3 2022 | Q2 2022 | Q1 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow | $-54M | $-60M | $-34M | $-45M | $-46M | $-63M | $-44M | $-46M | $-27M | $-33M | $-34M | $-37M | $86M | $-26M | $-29M | $-40M | |
| CapEx | $884.0K | $438.0K | $-1.0K | $248.0K | $306.0K | $165.0K | $86.0K | $383.0K | $52.0K | $417.0K | $198.0K | $72.0K | $489.0K | $457.0K | $492.0K | $208.0K | |
| Investing Cash Flow | $-123M | $-438.0K | $1.0K | $-248.0K | $-306.0K | $-165.0K | $-86.0K | $-383.0K | $-52.0K | $-417.0K | $-198.0K | $-72.0K | $-489.0K | $-501.0K | $25M | $-50M | |
| Stock Issued | · | · | · | · | · | · | · | $174M | $0 | $14M | $-35M | $-35M | $0 | $-229.0K | · | · | |
| Net Stock Activity | · | · | · | · | · | · | · | · | · | $14M | · | · | $35M | · | · | · | |
| Financing Cash Flow | $330.0K | $3M | $440M | $33M | $12M | $4M | $35M | $204M | $653.0K | $15M | $2M | $2M | $35M | $17.0K | $66M | $1M | |
| Net Change in Cash | $-177M | $-57M | $406M | $-12M | $-35M | $-59M | $-9M | $157M | $-27M | $-19M | $-33M | $-36M | $120M | $-26M | $61M | $-89M | |
| Free Cash Flow | · | $-60M | · | · | · | $-63M | · | · | · | $-34M | · | · | $85M | · | · | $-40M |
盈利能力 7
| 指标 | 趋势 | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q3 2023 | Q2 2023 | Q1 2023 | Q3 2022 | Q2 2022 | Q1 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating Margin | -3248.3% | -81.8% | · | · | -606.5% | -542.8% | · | · | -177.7% | -274.8% | 9.0% | -106.2% | -234.2% | -13648.8% | -11243.7% | -2176.8% | |
| Net Margin | -3052.6% | -68.2% | · | · | -580.2% | -510.9% | · | · | -167.2% | -251.7% | 14.7% | -95.5% | -212.0% | -13685.6% | -11012.3% | -2160.8% | |
| Pretax Margin | -3052.6% | -68.2% | · | · | -580.2% | -510.9% | · | · | -167.2% | -251.7% | 13.4% | -95.5% | -212.0% | -13685.6% | -11012.3% | -2160.8% | |
| EBITDA Margin | -3248.3% | -81.8% | · | · | -606.5% | -542.8% | · | · | -177.7% | -274.8% | 9.0% | -106.2% | -234.2% | -13648.8% | -11243.7% | -2176.8% | |
| ROA | -17.1% | -6.0% | · | -17.9% | -21.9% | -17.9% | · | -22.1% | -15.0% | -12.6% | 3.8% | -9.5% | -12.6% | -20.4% | -19.7% | -18.4% | |
| ROE | -23.4% | -7.6% | · | -40.5% | -74.3% | -47.5% | · | -122.2% | 119.3% | 676.9% | -32.2% | 203.2% | 157.7% | -307.3% | -156.5% | -143.3% | |
| ROIC | -16.3% | -6.1% | · | -45.2% | -37.9% | -29.0% | · | -45.1% | 1006.5% | -135.7% | -12.1% | 45.4% | 87.2% | 860.8% | -136.2% | 71875.5% |
流动性与偿付能力 2
| 指标 | 趋势 | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q3 2023 | Q2 2023 | Q1 2023 | Q3 2022 | Q2 2022 | Q1 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Current Ratio | 10.0 | 11.3 | · | 2.5 | 2.6 | 3.0 | · | 1.9 | 1.0 | 1.2 | 1.6 | 1.3 | 1.7 | 2.0 | 2.5 | 2.1 | |
| Quick Ratio | 7.3 | 10.9 | · | 2.4 | 2.4 | 2.8 | · | 1.8 | 0.9 | 1.1 | 1.5 | 1.2 | 1.6 | 1.9 | 2.3 | 1.9 |
效率 2
| 指标 | 趋势 | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q3 2023 | Q2 2023 | Q1 2023 | Q3 2022 | Q2 2022 | Q1 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Asset Turnover | 0.0 | 0.1 | · | · | 0.0 | 0.0 | · | · | 0.1 | 0.0 | 0.3 | 0.1 | 0.1 | 0.0 | 0.0 | 0.0 | |
| Receivables Turnover | 1.8 | · | · | · | 6.0 | · | · | · | 30.5 | 0.8 | 3.3 | · | · | · | · | · |
估值 (TTM) 10
| 指标 | 趋势 | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q3 2023 | Q2 2023 | Q1 2023 | Q3 2022 | Q2 2022 | Q1 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue TTM | · | · | · | · | · | · | · | $104M | $104M | $97M | $85M | $36M | $15M | $39M | $41M | · | |
| Net Income TTM | $-200M | $-177M | · | $-213M | $-192M | $-173M | · | $-119M | $-78M | $-73M | $-80M | $-129M | $-146M | $-124M | $-124M | $-125M | |
| Market Cap | $1.12B | $1.39B | · | $1.17B | $1.01B | $1.25B | · | $1.22B | $611M | $755M | $569M | $359M | $425M | $313M | $282M | $122M | |
| P/E | -5.3 | -6.9 | · | -5.3 | -4.9 | -6.5 | · | -9.2 | -8.0 | -9.6 | -7.0 | -2.4 | -2.2 | -2.0 | -1.5 | · | |
| P/S | · | · | · | · | · | · | · | 11.8 | 5.9 | 7.8 | 6.7 | 10.1 | 27.7 | 8.1 | 6.8 | · | |
| P/B | 2.5 | 2.7 | · | 9.4 | 7.3 | 7.2 | · | 8.6 | -175.8 | 29.7 | -14.1 | -6.9 | -12.2 | -69.4 | 9.1 | -2296.6 | |
| P / Tangible Book | 2.5 | 2.7 | · | 9.4 | 7.3 | 7.2 | · | 8.6 | · | 29.7 | · | · | · | · | 9.1 | · | |
| P / Cash Flow | · | -23.4 | · | · | · | -19.8 | · | · | · | -22.6 | · | · | 5.0 | · | · | -3.1 | |
| P / FCF | · | -23.2 | · | · | · | -19.7 | · | · | · | -22.3 | · | · | 5.0 | · | · | -3.0 | |
| Earnings Yield | -18.9% | -14.5% | · | -19.0% | -20.3% | -15.5% | · | -10.8% | -12.4% | -10.4% | -14.3% | -41.5% | -44.6% | -49.3% | -65.8% | · |
财务报表 损益表、资产负债表、现金流量表 — 年度，近5年
损益表
| 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 | |
|---|---|---|---|---|---|
| 收入 | $43M | $108M | $113M | $4M | $41M |
| 净收入 | $-204M | $-97M | $-58M | $-162M | $-122M |
| 稀释后每股收益 (EPS) | $-1.21 | $-0.70 | $-0.54 | $-2.05 | $-2.36 |
最新新闻 提及该公司的近期头条新闻
我的指标 您的个人关注列表 — 来自完整基本面的选定行
📊
选择对您重要的指标 — 点击上方完整基本面中任意行的 ➕。
您的选择已保存，并会跟随您浏览所有股票。
机构持有人 (13F) 264 家申报者 · $892.5M 总计 · 截至 2026年6月30日
在其季度SEC表格13F中报告持有此股票的机构。仅限多头头寸；单个申报人可能因单独的期权腿而出现两次。 大的抵消性看跌/看涨腿通常反映做市或对冲库存，而非方向性判断。
机构活动 — Q2 2026 与上一季度对比
| 新仓位 | 已退出持仓 | 增加 | 减少 | 净股数变动 |
|---|---|---|---|---|
| 56 (-1 与上一季度对比) | 37 (+1 与上一季度对比) | 93 (-18 与上一季度对比) | 59 (+4 与上一季度对比) | +13.0M |
与Q1 2026对比。 SEC 13F表格的提交截止日期是季度末后45天，外加少量延迟提交的缓冲期——在此窗口期内的季度将被跳过，优先显示最近一个已完整报告的季度对。
| 机构 | 价值 | 股份 | % 已追踪的13F | 类型 |
|---|---|---|---|---|
| RA CAPITAL MANAGEMENT, L.P. | $156727684 | 26975505 | 17.56% | 股份 |
| GSK plc | $106007465 | 18245691 | 11.88% | 股份 |
| MAVERICK CAPITAL LTD | $59715848 | 10278115 | 6.69% | 股份 |
| Driehaus Capital Management LLC | $31624661 | 5443143 | 3.54% | 股份 |
| PRIMECAP MANAGEMENT CO/CA/ | $31110354 | 5354622 | 3.49% | 股份 |
| 683 Capital Management, LLC | $28759500 | 4950000 | 3.22% | 股份 |
| STATE STREET CORP | $28116432 | 4839317 | 3.15% | 股份 |
| READYSTATE ASSET MANAGEMENT LP | $27464678 | 4727139 | 3.08% | 股份 |
| M28 Capital Management LP | $26657930 | 4588284 | 2.99% | 股份 |
| TWO SIGMA INVESTMENTS, LP | $21541656 | 3707686 | 2.41% | 股份 |
| GEODE CAPITAL MANAGEMENT, LLC | $19277729 | 3317246 | 2.16% | 股份 |
| FMR LLC | $17099004 | 2943030 | 1.92% | 股份 |
| ALGERT GLOBAL LLC | $16370343 | 2817615 | 1.83% | 股份 |
| Qube Research & Technologies Ltd | $16128560 | 2776000 | 1.81% | 股份 |
| Squarepoint Ops LLC | $14765778 | 2541442 | 1.65% | 股份 |
| VANGUARD GROUP INC | $14386233 | 846249 | 1.61% | 股份 |
| VANGUARD PORTFOLIO MANAGEMENT LLC | $12263463 | 2110751 | 1.37% | 股份 |
| MORGAN STANLEY | $12000799 | 2065542 | 1.34% | 股份 |
| Pfizer Inc | $10931250 | 1875000 | 1.22% | 股份 |
| MILLENNIUM MANAGEMENT LLC | $10523548 | 1811282 | 1.18% | 股份 |
| D. E. Shaw & Co., Inc. | $10296645 | 1772228 | 1.15% | 股份 |
| VANGUARD CAPITAL MANAGEMENT LLC | $10175651 | 1751403 | 1.14% | 股份 |
| SCHRODER INVESTMENT MANAGEMENT GROUP | $9920932 | 1746643 | 1.11% | 股份 |
| RENAISSANCE TECHNOLOGIES LLC | $9903261 | 1704520 | 1.11% | 股份 |
| DIMENSIONAL FUND ADVISORS LP | $9201210 | 1583685 | 1.03% | 股份 |
| GOLDMAN SACHS GROUP INC | $8877262 | 1527928 | 0.99% | 股份 |
| Point72 Asset Management, L.P. | $8627786 | 1484989 | 0.97% | 股份 |
| RTW INVESTMENTS, LP | $7843500 | 1350000 | 0.88% | 股份 |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC | $7114025 | 1224445 | 0.80% | 股份 |
| EMERALD ADVISERS, LLC | $7111237 | 1223965 | 0.80% | 股份 |
| BlackRock, Inc. | $5539777 | 953490 | 0.62% | 股份 |
| SymBiosis Capital Partners, LLC | $5437500 | 750000 | 0.61% | 股份 |
| Pictet Asset Management Holding SA | $5330146 | 917409 | 0.60% | 股份 |
| VANGUARD FIDUCIARY TRUST CO | $5157403 | 887677 | 0.58% | 股份 |
| Aberdeen Group plc | $5092221 | 876458 | 0.57% | 股份 |
| EMERALD MUTUAL FUND ADVISERS TRUST | $4926874 | 847999 | 0.55% | 股份 |
| BAKER BROS. ADVISORS LP | $4779527 | 822638 | 0.54% | 股份 |
| BNP PARIBAS FINANCIAL MARKETS | $4712241 | 811057 | 0.53% | 股份 |
| CAPITAL FUND MANAGEMENT S.A. | $4268874 | 734746 | 0.48% | 股份 |
| SPHERA FUNDS MANAGEMENT LTD. | $3708360 | 638272 | 0.42% | 股份 |
| Y-Intercept (Hong Kong) Ltd | $3544646 | 610094 | 0.40% | 股份 |
| Susquehanna Portfolio Strategies, LLC | $3533607 | 608194 | 0.40% | 股份 |
| TANG CAPITAL MANAGEMENT LLC | $3486000 | 600000 | 0.39% | 股份 |
| Walleye Capital LLC | $3401482 | 585453 | 0.38% | 股份 |
| CITADEL ADVISORS LLC | $2789695 | 480154 | 0.31% | 股份 |
| BANK OF AMERICA CORP /DE/ | $2569042 | 442176 | 0.29% | 股份 |
| XTX Topco Ltd | $2556011 | 439933 | 0.29% | 股份 |
| Universal- Beteiligungs- und Servicegesellschaft mbH | $2375674 | 408894 | 0.27% | 股份 |
| Connor, Clark & Lunn Investment Management Ltd. | $2319398 | 399208 | 0.26% | 股份 |
| Trexquant Investment LP | $2208782 | 380169 | 0.25% | 股份 |
| HSBC HOLDINGS PLC | $2172683 | 370449 | 0.24% | 股份 |
| Woodline Partners LP | $2036585 | 350531 | 0.23% | 股份 |
| Ishara Investments LP | $1905680 | 328000 | 0.21% | 股份 |
| BARCLAYS PLC | $1766839 | 304103 | 0.20% | 股份 |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | $1739514 | 299400 | 0.19% | 股份 |
| PLATINUM INVESTMENT MANAGEMENT LTD | $1599313 | 275269 | 0.18% | 股份 |
| JPMORGAN CHASE & CO | $1543989 | 265614 | 0.17% | 股份 |
| Swiss National Bank | $1514086 | 260600 | 0.17% | 股份 |
| ExodusPoint Capital Management, LP | $1458728 | 251072 | 0.16% | 股份 |
| Privium Fund Management B.V. | $1400268 | 241010 | 0.16% | 股份 |
| F/m Investments LLC | $1365844 | 235085 | 0.15% | 股份 |
| MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. | $1339112 | 230484 | 0.15% | 股份 |
| Newtyn Management, LLC | $1249150 | 215000 | 0.14% | 股份 |
| TD Asset Management Inc | $1127291 | 194026 | 0.13% | 股份 |
| ALPS ADVISORS INC | $1125780 | 193766 | 0.13% | 股份 |
| RHUMBLINE ADVISERS | $1125195 | 193667 | 0.13% | 股份 |
| Sofinnova Investments, Inc. | $1099560 | 189253 | 0.12% | 股份 |
| CALIFORNIA STATE TEACHERS RETIREMENT SYSTEM | $1052744 | 145206 | 0.12% | 股份 |
| Elmind Capital, LP | $1033285 | 177846 | 0.12% | 股份 |
| ADAR1 Capital Management, LLC | $929600 | 160000 | 0.10% | 股份 |
| Bank of New York Mellon Corp | $911560 | 156895 | 0.10% | 股份 |
| ALLIANCEBERNSTEIN L.P. | $904293 | 124730 | 0.10% | 股份 |
| Burkehill Global Management, LP | $871500 | 150000 | 0.10% | 股份 |
| BOOTHBAY FUND MANAGEMENT, LLC | $842450 | 145000 | 0.09% | 股份 |
| MANUFACTURERS LIFE INSURANCE COMPANY, THE | $836692 | 144009 | 0.09% | 股份 |
| STATE OF WISCONSIN INVESTMENT BOARD | $830981 | 143026 | 0.09% | 股份 |
| WELLINGTON MANAGEMENT GROUP LLP | $801995 | 138037 | 0.09% | 股份 |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | $775635 | 133500 | 0.09% | 买入期权 |
| CITIGROUP INC | $680287 | 117089 | 0.08% | 股份 |
| WELLS FARGO & COMPANY/MN | $675395 | 116247 | 0.08% | 股份 |
| James J. Burns & Company, LLC | $666988 | 114800 | 0.07% | 股份 |
| IEQ CAPITAL, LLC | $618451 | 106446 | 0.07% | 股份 |
| Cetera Investment Advisers | $609341 | 104878 | 0.07% | 股份 |
| LOS ANGELES CAPITAL MANAGEMENT LLC | $608336 | 104705 | 0.07% | 股份 |
| VANGUARD ASSET MANAGEMENT, Ltd | $604211 | 103995 | 0.07% | 股份 |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | $593782 | 102200 | 0.07% | 卖出期权 |
| Mariner, LLC | $593759 | 102195 | 0.07% | 股份 |
| Bridgefront Capital, LLC | $589448 | 101454 | 0.07% | 股份 |
| UBS Group AG | $531034 | 91400 | 0.06% | 买入期权 |
| MetLife Investment Management, LLC | $513587 | 88397 | 0.06% | 股份 |
| Ikarian Capital, LLC | $495507 | 85285 | 0.06% | 股份 |
| NOMURA ASSET MANAGEMENT INTERNATIONAL INC. | $476000 | 81955 | 0.05% | 股份 |
| Entropy Technologies, LP | $467409 | 80449 | 0.05% | 股份 |
| EXCHANGE TRADED CONCEPTS, LLC | $467310 | 80432 | 0.05% | 股份 |
| Quadrature Capital Ltd | $459368 | 79065 | 0.05% | 股份 |
| SUSQUEHANNA FUNDAMENTAL INVESTMENTS, LLC | $451007 | 77626 | 0.05% | 股份 |
| a16z Perennial Management, L.P. | $450966 | 77619 | 0.05% | 股份 |
| MARSHALL WACE, LLP | $443645 | 76359 | 0.05% | 股份 |
| Zurcher Kantonalbank (Zurich Cantonalbank) | $432450 | 74432 | 0.05% | 股份 |
| FEDERATED HERMES, INC. | $408304 | 70276 | 0.05% | 股份 |
公司内部人士 21 位内幕人士 · 8 位高管 · 9 位董事
| 内部人士 | 角色 | 上次活动 | 持股数量 | 买入 12个月 | 卖出 12个月 | 净额 12个月 |
|---|---|---|---|---|---|---|
| Paul Bolno | President and CEO | 2026年2月5日 A | 275520 | 0 | 2 | $-2336201 |
| Kyle Moran | Chief Financial Officer | 2026年2月5日 A | 134385 | 0 | 7 | $-4151988 |
| David G Gaiero | Interim CFO | 2020年3月3日 A | 6392 | 0 | 0 | $0 |
| Keith Regnante | Chief Financial Officer | 2019年3月7日 A | 29186 | 0 | 0 | $0 |
| Chris Francis | SVP, Corporate Development, Head of Emerging Areas | 2026年2月26日 M | 61867 | 0 | 14 | $-7103233 |
| Chandra Vargeese | Chief Technology Officer, Head of Platform Discovery Sciences | 2026年2月5日 A | 408246 | 0 | 1 | $-43417 |
| Michael A. Panzara | Chief Medical Officer, Head of Therapeutics Discovery and Development | 2022年7月25日 A | 109103 | 0 | 0 | $0 |
| Mark Baldry | Chief Commerical Officer | 2019年8月5日 A | 39000 | 0 | 0 | $0 |
| Gregory L. Verdine | 董事 | 2025年12月8日 S | 275217 | 0 | 3 | $-369461 |
| Christian O Henry | 董事 | 2025年12月8日 M | 12700 | 0 | 4 | $-1369324 |
| Mark Corrigan | 董事 | 2025年12月8日 S | 28815 | 0 | 2 | $-217265 |
| Amy Pott | 董事 | 2020年8月18日 A | — | 0 | 0 | $0 |
| Peter Kolchinsky | 董事 | 2020年8月18日 A | — | 0 | 0 | $0 |
| Koji Miura | 董事 | 2019年8月15日 A | — | 0 | 0 | $0 |
| Masaharu Tanaka | 董事 | 2016年11月10日 A | — | 0 | 0 | $0 |
| Takeshi Wada | 董事 | 2016年11月10日 A | — | 0 | 0 | $0 |
| Adrian Rawcliffe | — | 2026年8月12日 S | 0 | 0 | 3 | $-806604 |
| Tan Aik Na | — | 2026年8月11日 S | 24968 | 0 | 9 | $-1825754 |
| Ken Takanashi | — | 2026年8月11日 S | 20079 | 0 | 1 | $-23223 |
| Heidi L Wagner | — | 2026年8月11日 M | 44930 | 0 | 3 | $-231070 |
| Roberto Guerciolini | — | 2016年12月7日 M | 4000 | 0 | 0 | $0 |
来自SEC表格3/4/5申报的内部人士；净额=仅公开市场买卖
激进投资者及 5%+ 股东 4 持仓
提交了 SEC Schedule 13D 的投资者 — 持有超过 5% 的受益所有权，意图影响发行人（激进股东持股、董事会活动、并购）。每一行显示该申报人持仓的最新已知状态。
| 申报人 | 已申报 | 持股 | 状态 | 目的 | 申报 |
|---|---|---|---|---|---|
| RA Capital Management, L.P., Peter Kolchinsky, Rajeev Shah, RA Capital Healthcare Fund, L.P. ×9 申报 | 2026年8月11日 | 16.80% | 修订 | — | SEC |
| Shin Nippon Biomedical Laboratories, Ltd., SNBL USA, Ltd., Ken Takanashi ×6 申报 | 2022年8月12日 | — | 初始申报 | — | SEC |
| Kagoshima Shinsangyo Sousei Investment Limited Partnership, Kagoshima Development Co. Ltd. ×5 申报 | 2022年7月20日 | — | 初始申报 | — | SEC |
| RA Capital Management, LLC, Peter Kolchinsky ×3 申报 | 2019年1月28日 | — | 初始申报 | 被动投资 | SEC |
Purpose is an automated classification of the filer's own stated purpose (SEC Item 4) — not investment advice. "—" means no clear purpose was stated or the text could not be classified.
ETF持仓 由 30 只交易所交易基金持有
权重仅反映直接股权持仓（N-PORT）；杠杆基金或基于衍生品的基金可能持有未显示的额外掉期敞口。
| 基金 | 权重 | 单位 | 截至 | 来源 |
|---|---|---|---|---|
| GNOM · Global X Funds | 1.03% | 87259 NS | 2026年5月31日 | N-PORT |
| PILL · Direxion Shares ETF Trust | 0.67% | 12254 NS | 2026年4月30日 | N-PORT |
| RSSL · Global X Funds | 0.03% | 60562 NS | 2026年4月30日 | N-PORT |
| DFAS · Dimensional ETF Trust | 0.01% | 250409 NS | 2026年4月30日 | N-PORT |
| MSSM · MORGAN STANLEY PATHWAY FUNDS | 0.00% | 4467 NS | 2026年5月31日 | N-PORT |
| DFAU · Dimensional ETF Trust | 0.00% | 43085 NS | 2026年4月30日 | N-PORT |
| DXUV · Dimensional ETF Trust | 0.00% | 1463 NS | 2026年4月30日 | N-PORT |
| DCOR · Dimensional ETF Trust | 0.00% | 10250 NS | 2026年4月30日 | N-PORT |
| DFAC · Dimensional ETF Trust | 0.00% | 74011 NS | 2026年4月30日 | N-PORT |
| DFUS · Dimensional ETF Trust | 0.00% | 18648 NS | 2026年4月30日 | N-PORT |
| VXF · VANGUARD INDEX FUNDS | — | — | 2026年7月15日 | 每日 |
| VTWO · VANGUARD SCOTTSDALE FUNDS | — | — | 2026年7月15日 | 每日 |
| VTWV · VANGUARD SCOTTSDALE FUNDS | — | — | 2026年7月15日 | 每日 |
| VTWG · VANGUARD SCOTTSDALE FUNDS | — | — | 2026年7月15日 | 每日 |
| VTHR · VANGUARD SCOTTSDALE FUNDS | — | — | 2026年7月15日 | 每日 |
| ITOT · iShares Trust | — | — | 2026年8月12日 | 每日 |
| IWV · iShares Trust | — | — | 2026年8月18日 | 每日 |
| IWN · iShares Trust | — | — | 2026年8月17日 | 每日 |
| IWO · iShares Trust | — | — | 2026年8月18日 | 每日 |
| IWM · iShares Trust | — | — | 2026年8月18日 | 每日 |
| IBB · iShares Trust | — | — | 2026年8月18日 | 每日 |
| IWC · iShares Trust | — | — | 2026年8月18日 | 每日 |
| IHE · iShares Trust | — | — | 2026年8月18日 | 每日 |
| PRFZ · Invesco Exchange-Traded Fund Trust | — | — | 2026年8月11日 | 每日 |
| VHT · VANGUARD WORLD FUND | — | — | 2026年7月20日 | 每日 |
| ISCB · iShares Trust | — | — | 2026年8月12日 | 每日 |
| ISCG · iShares Trust | — | — | 2026年8月12日 | 每日 |
| ISCV · iShares Trust | — | — | 2026年8月12日 | 每日 |
| WSML · iShares Trust | — | — | 2026年8月12日 | 每日 |
| IBBQ · Invesco Exchange-Traded Fund Trus... | — | — | 2026年8月11日 | 每日 |